Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Aryl Secondary Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100554403C reveals Microbacterium oxydans for high-purity chiral alcohol. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN101085990A reveals chemo-enzymatic route for high-purity chiral alcohols. Enables cost reduction and supply chain reliability for pharmaceutical intermediates.
Analysis of patent CN101085990B reveals a chemo-enzymatic route for high-purity chiral alcohols. This method offers significant supply chain stability and cost reduction advantages for pharmaceutical intermediate manufacturing.